Economic burden of alcohol-related cancers in the Republic of Korea

Drug Alcohol Depend. 2020 Dec 1:217:108295. doi: 10.1016/j.drugalcdep.2020.108295. Epub 2020 Sep 15.

Abstract

Background: Cancer is a major burden of disease and alcohol consumption is one of the major risk factors of cancer. This study aimed to estimate the economic burden of cancer types attributable to alcohol consumption in the Republic of Korea.

Methods: This study estimates the direct and indirect costs of cancer types attributable to alcohol consumption by applying cost-of-illness methods using the human capital approach and prevalence-based estimates. Claims data from the National Health Insurance Service for 2011-2016 were used.

Results: In Korea, there were 297,304 alcohol consumption-related cancer cases, of which 14,186 (4.8 %) were attributable to alcohol consumption in 2016. From 2011-2016, the socioeconomic burden of cancer attributable to alcohol consumption in Korea has increased steadily, even considering inflation adjustment. The total economic burden of cancer attributable to alcohol consumption in 2016 in Korea was approximately $476 million, of which $119 million were direct costs and $357 million were indirect costs. According to our analysis of annual cost per patient, the average costs were $37,432 for men and $11,930 for women.

Conclusions: The economic burden of cancer types attributable to alcohol consumption in Korea is substantial and has increased between 2011 and 2016, mainly due to an increased number of patients.

Keywords: Alcohol; Cancer; Cost; Economic burden; Korea.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Alcohol Drinking / adverse effects
  • Alcohol Drinking / economics*
  • Alcohol Drinking / epidemiology*
  • Cost of Illness*
  • Female
  • Health Care Costs / trends*
  • Humans
  • Insurance Claim Reporting / economics
  • Insurance Claim Reporting / trends
  • Male
  • Middle Aged
  • Neoplasms / economics*
  • Neoplasms / epidemiology*
  • Neoplasms / therapy
  • Prevalence
  • Republic of Korea / epidemiology
  • Risk Factors